Cosmecca Korea announced on the 25th that, as a result of the tender offer for Englewood Lab conducted from March 3 to 23, the number of shares tendered (3,352,950 shares) exceeded the planned quantity (3,311,310 shares).


The tender offer targeted Englewood Lab’s Korea Depositary Receipts (KDRs), representing 16.67% of the total issued shares. In 2016, Englewood Lab, a U.S. corporation, was listed on KOSDAQ through the issuance of KDRs.



As a result of this tender offer, the combined stake of Cosmecca Korea and its special affiliates in Englewood Lab increased from 55.08% to 71.75%.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing